Review of current thermal ablation treatment for lung cancer and the potential of electrochemotherapy as a means for treatment of lung tumours

Cancer Treatment Reviews

Volumn 39, Issue 8, 2013, Pages 862-871

  Jahangeer, Saleem ^a,b   Forde, Patrick ^b   Soden, Declan ^b   Hinchion, John ^a  

^a University College Cork and INFANT Centre   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cryoablation; Electrochemotherapy; Electroporation; Lung cancer; Microwave Ablation; Non small cell lung cancer; Radiofrequency ablation; Thermal Ablation

Indexed keywords

BLEOMYCIN; CISPLATIN;

ADULT RESPIRATORY DISTRESS SYNDROME; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; COLORECTAL CANCER; CONSERVATIVE TREATMENT; COUGHING; CRYOABLATION; ELECTROCHEMOTHERAPY; ELECTROPORATION; HEART FAILURE; HEART INFARCTION; HEMOPTYSIS; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG INFECTION; MICROWAVE THERAPY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NERVE PARALYSIS; NEUROPATHY; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; RADIOFREQUENCY ABLATION; RESPIRATORY ARREST; RESPIRATORY FAILURE; REVIEW; STANDARD; SYSTEMATIC REVIEW (TOPIC); THERMAL ABLATION; THORACOTOMY; TREATMENT RESPONSE; TUMOR ABLATION;

EID: 84883554462     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.03.007     Document Type: Review

References (126)

1. National Lung Cancer Audit - LUCADA, http://www.ic.nhs.uk.
2. Lung cancer incidence Mortality, treatment and survival in the Republic of Ireland: 1994-2008 2011, National Cancer Registry, Cork, Ireland.
3. Office for National Statistics (ONS) SRiE, patients diagnosed 2001-2006 followed up to 2007, http://www.ons.co.uk.
4. El-Sherif A., Gooding W.E., Santos R., Pettiford B., Ferson P.F., Fernando H.C., et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006, 82(2):408-416.
5. Cancer Research UK Survival Data 2010. Lung Cancer incidence and statistics, http://cancerresearchuk.org.
6. Garcea G., Thomasset S., Berry D.P., Tordoff S. Percutaneous splanchnic nerve radiofrequency ablation for chronic abdominal pain. ANZ J Surg 2005, 75(8):640-644.
7. Gazelle G.S., Goldberg S.N., Solbiati L., Livraghi T. Tumor ablation with radio-frequency energy1. Radiology 2000, 217(3):633-646.
8. Nikfarjam M., Muralidharan V., Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005, 127(2):208-223.
9. Goldberg S.N., Gazelle G.S., Halpern E.F., Rittman W.J., Mueller P.R., Rosenthal D.I. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996, 3(3):212-218.
10. Nahum Goldberg S., Scott Gazelle G., Compton C.C., Mueller P.R., McLoud T.C. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996, 3(11):929-935.
11. Miao Y., Ni Y., Bosmans H., Yu J., Vaninbroukx J., Dymarkowski S., et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001, 99(2):265-271.
12. Yang S, Whyte R, Askin F, et al. Radiofrequency ablation of primary and metastatic lung tumors. Analysis of an ablate and resection study, 2002. In: American Association for Thoracic Surgery 82nd Annual Meeting; Washington, DC.
13. Nguyen C.L., Scott W.J., Young N.A., Rader T., Giles L.R., Goldberg M. Radiofrequency ablation of primary lung cancer*. Chest 2005, 128(5):3507-3511.
14. Ambrogi M.C., Fontanini G., Cioni R., Faviana P., Fanucchi O., Mussi A. Biologic effects of radiofrequency thermal ablation on nonâ€"small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 2006, 131(5):1002-1006.
15. Zhu J.C., Yan T.D., Morris D.L. A systematic review of radiofrequency ablation for lung tumors. Ann of Surg Oncol 2008, 15(6):1765-1774.
16. Hiraki T., Gobara H., Mimura H., Toyooka S., Fujiwara H., Yasui K., et al. Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10years of experience. Acta medica Okayama 2011, 65(5):287.
17. Abbas G., Pennathur A., Landreneau R.J., Luketich J.D. Radiofrequency and microwave ablation of lung tumors. J Surg Oncol 2009, 100(8):645-650.
18. Simon C.J., Dupuy D.E., DiPetrillo T.A., Safran H.P., Grieco C.A., Ng T., et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients1. Radiology 2007, 243(1):268.
19. Pennathur A., Luketich J.D., Abbas G., Chen M., Fernando H.C., Gooding W.E., et al. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients. J Thorac Cardiovasc Surg 2007, 134(4):857-864.
20. Lanuti M., Sharma A., Digumarthy S.R., Wright C.D., Donahue D.M., Wain J.C., et al. Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2009, 137(1):160-166.
21. Lencioni R., Crocetti L., Cioni R., Suh R., Glenn D., Regge D., et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008, 9(7):621-628.
22. Ambrogi M.C., Fanucchi O., Cioni R., Dini P., De Liperi A., Cappelli C., et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study. J Thorac Oncol 2011, 6(12):2044-2051.
23. Bojarski J.D., Dupuy D.E., Mayo-Smith W.W. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. Am J Roentgenol 2005, 185(2):466-471.
24. Okuma T., Matsuoka T., Yamamoto A., Oyama Y., Inoue K., Nakamura K., et al. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 2007, 18(3):399-404.
25. Ambrogi M.C., Fanucchi O., Cioni R., Dini P., De Liperi A., Cappelli C., et al. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study 2011, J Thorac Oncol.
26. Sonntag P.D., Hinshaw J.L., Lubner M.G., Brace C.L., Lee F.T. Thermal ablation of lung tumors. Surgical oncology clinics of North America 2011, 20(2):369-387.
27. Okuma T., Okamura T., Matsuoka T., Yamamoto A., Oyama Y., Toyoshima M., et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 2006, 20(2):115-121.
28. Pua B.B., Thornton R.H., Solomon S.B. Ablation of pulmonary malignancy: current status. J Vasc Interv Radiol 2010, 21(8):S223-S232.
29. Okuma T., Matsuoka T., Yamamoto A., Hamamoto S., Nakamura K., Inoue Y. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 2009, 82(984):989.
30. Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45(2):228-247.
31. Herrera L.J., Fernando H.C., Perry Y., Gooding W.E., Buenaventura P.O., Christie N.A., et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003, 125(4):929.
32. Hiraki T., Gobara H., Mimura H., Matsui Y., Toyooka S., Kanazawa S. Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2011, 142(1):24-30.
33. Hiraki T., Gobara H., Iishi T., Sano Y., Iguchi T., Fujiwara H., et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J Thorac Cardiovasc Surg 2007, 134(5):1306-1312.
34. Pennathur A., Abbas G., Schuchert M., Landreneau R.J., Luketich J.D. Radiofrequency ablation for the treatment of lung neoplasm. Expert Rev Med Devices 2008, 5(5):613-621.
35. Hiraki T., Sakurai J., Tsuda T., Gobara H., Sano Y., Mukai T., et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors. Cancer 2006, 107(12):2873-2880.
36. Lee J.M., Jin G.Y., Goldberg S.N., Lee Y.C., Chung G.H., Han Y.M., et al. Percutaneous radiofrequency ablation for inoperable Nonâ€"small cell lung cancer and metastases: preliminary report1. Radiology 2004, 230(1):125.
37. Yamamoto A., Nakamura K., Matsuoka T., Toyoshima M., Okuma T., Oyama Y., et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. Am J Roentgenol 2005, 185(5):1299-1306.
38. Hiraki T., Tajiri N., Mimura H., Yasui K., Gobara H., Mukai T., et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors1. Radiology 2006, 241(1):275-283.
39. Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol; 21(8): S192-S203.
40. Simon C.J., Dupuy D.E., Mayo-Smith W.W. Microwave ablation: principles and applications1. Radiographics 2005, 25(suppl 1):S69-S83.
41. Yu N.C., Raman S.S., Kim Y.J., Lassman C., Chang X., Lu D.S.K. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol 2008, 19(7):1087-1092.
42. Gabriel S., Lau R.W., Gabriel C. The dielectric properties of biological tissues: II. Measurements in the frequency range 10-20GHz. Phys Med Biol 1996, 41:2251.
43. Crocetti L., Bozzi E., Faviana P., Cioni D. Della Pina C, Sbrana A et al. Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency. Cardiovascular and interventional radiology 2010, 33(4):818-827.
44. Durick N.A., Laeseke P.F., Broderick L.S., Lee F.T., Sampson L.A., Frey T.M., et al. Microwave ablation with triaxial antennas tuned for lung: results in an in Vivo porcine model1. Radiology 2008, 247(1):80-87.
45. Sun Y., Wang Y., Ni X., Gao Y., Shao Q., Liu L., et al. Comparison of ablation zone between 915-and 2450-MHz cooled-shaft microwave antenna: results in in vivo porcine livers. Am J Roentgenol 2009, 192(2):511-514.
46. Bertram J.M., Yang D., Converse M.C., Webster J.G., Mahvi D.M. Antenna design for microwave hepatic ablation using an axisymmetric electromagnetic model. Biomed Eng Online 2006, 5:15.
47. Brace C.L. Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 2009, 38(2):61-67.
48. Brace C.L., Hinshaw J.L., Laeseke P.F., Sampson L.A., Lee F.T. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model1. Radiology 2009, 251(3):705.
49. He W., Hu X., Wu D., Guo L., Zhang L., Xiang D., et al. Ultrasonography-guided percutaneous microwave ablation of peripheral lung cancer. Clin Imaging 2006, 30(4):234-241.
50. Feng W., Liu W., Li C., Li Z., Li R., Liu F., et al. Percutaneous microwave coagulation therapy for lung cancer. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2002, 24(4):388.
51. Wolf F.J., Grand D.J., Machan J.T., DiPetrillo T.A., Mayo-Smith W.W., Dupuy D.E. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients1. Radiology 2008, 247(3):871.
52. Carrafiello G., Mangini M., Fontana F., Di Massa A., Ierardi A.M., Cotta E., et al. Complications of microwave and radiofrequency lung ablation: personal experience and review of the literature. La Radiol Med 2012, 117(2):201-203.
53. Ohmoto K., Yoshioka N., Tomiyama Y., Shibata N., Kawase T., Yoshida K., et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: a retrospective comparative study. Hepato-gastroenterology 2007, 54(76):985.
54. Gage A.A., Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998, 37(3):171-186.
55. McTaggart R.A., Dupuy D.E. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 2007, 10(2):102-113.
56. Littrup P.J., Mody A., Sparschu R., Prchevski P., Montie J., Zingas A.P., et al. Prostatic cryotherapy: ultrasonographicand pathologic correlation in the canine model. Urology 1994, 44(2):175-183.
57. Wang H., Littrup P.J., Duan Y., Zhang Y., Feng H., Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures1. Radiology 2005, 235(1):289.
58. Kawamura M., Izumi Y., Tsukada N., Asakura K., Sugiura H., Yashiro H., et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006, 131(5):1007-1013.
59. Goldberg S.N. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001, 13(2):129-147.
60. Goldberg S.N., Solbiati L., Hahn P.F., Cosman E., Conrad J.E., Fogle R., et al. Large-volume tissue ablation with radio frequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998, 209(2):371.
61. Crocetti L., Lencioni R., Bozzi E., Sbrana A., Bartolozzi C. Lung radiofrequency ablation: in vivo experimental study with low-perfusion-rate multitined electrodes. Cardiovasc Interv Radiol 2008, 31(3):610-618.
62. Lee J.M., Han J.K., Chang J.M., Chung S.Y., Kim S.H., Lee J.Y., et al. Radiofrequency ablation in pig lungs: in vivo comparison of internally cooled, perfusion and multitined expandable electrodes. Br J Radiol 2006, 79(943):562.
63. Hiraki T., Gobara H., Sakurai J., Mimura H., Mukai T., Hase S., et al. Radiofrequency ablation of normal lungs after pulmonary artery embolization with use of degradable starch microspheres: results in a porcine model. J Vasc Interv Radiol 2006, 17(12):1991-1998.
64. Anai H., Uchida B.T., Pavcnik D., Seong C.K., Baker P., Correa L.O., et al. Effects of blood flow and/or ventilation restriction on radiofrequency coagulation size in the lung: an experimental study in swine. Cardiovasc Interv Radiol 2006, 29(5):838-845.
65. Oshima F., Yamakado K., Akeboshi M., Takaki H., Nakatsuka A., Makita M., et al. Lung radiofrequency ablation with and without bronchial occlusion: experimental study in porcine lungs. J Vasc Interv Radiol 2004, 15(12):1451-1456.
66. Ambrogi M.C., Lucchi M., Dini P., Melfi F., Fontanini G., Faviana P., et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothoracic Surg 2006, 30(1):177-183.
67. Nomura M., Yamakado K., Nomoto Y., Nakatsuka A., Ii N., Takaki H., et al. Complications after lung radiofrequency ablation: risk factors for lung inflammation. Br J Radiol 2008, 81(963):244.
68. Weaver J.C. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 1993, 51:426.
69. Neumann E., Schaefer-Ridder M., Wang Y., Hofschneider P.H. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982, 1(7):841.
70. Orlowski S., Mir L.M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta (BBA)-Reviews onBiomembranes 1993, 1154(1):51-63.
71. Weaver J.C., Chizmadzhev Y.A. Theory of electroporation: a review. Bioelectrochemistry and Bioenergetics 1996, 41(2):135-160.
72. Lopez A., Rols M.P., Teissie J. 31P NMR analysis of membrane phospholipid organization in viable, reversibly electropermeabilized Chinese hamster ovary cells. Biochemistry 1988, 27(4):1222.
73. Teissie J., Rols M.P. An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys J 1993, 65(1):409-413.
74. Kinosita K., Tsong T.Y. Voltage-induced pore formation and hemolysis of human erythrocytes. Biochim Biophys Acta 1977, 471(2):227-242.
75. Mir L.M., Orlowski S. Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 1999, 35(1):107-118.
76. Poddevin B., Orlowski S., Belehradek J. Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmaco 1991, 42:S67-S75.
77. Orlowski S., Belehradek J., Paoletti C., Mir L.M. Transient electropermeabilization of cells in culture: increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988, 37(24):4727-4733.
78. Casabianca-Pignà de M.R., Mir L.M., Le Pecq J.B., Jacquemin-Sablon A. Stability of antiricin antibodies introduced into DC-3F Chinese hamster cells by electropermeabilization. J Cell Pharmacol 1991, 2:54-60.
79. Rols M.P., Teissie J. Ionical strength modulation of electrically induced permeabilization and associated fusion of mammalian cells. Eur J Biochem 1989, 179(1):109-115.
80. Kinosita K., Tsong T.Y. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 1997, 268:438-441.
81. Rols M.P., Dahhou F., Mishra K.P., Teissie J. Control of electric field induced cell membrane permeabilization by membrane order. Biochemistry 1990, 29(12):2960-2966.
82. Teissie J., Rols M.P. Manipulation of cell cytoskeleton affects the lifetime of cell membrane electropermeabilization. Annals New York Acad Sci 1994, 720(1):98-110.
83. Gehl J., Skovsgaard T., Mir L.M. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta (BBA)-General Subjects 2002, 1569(1-3):51-58.
84. Mir L.M. Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 2006, 4(11):38-44.
85. Engstrom P.E., Persson B.R.R., Salford L.G. Studies of in vivo electropermeabilization by gamma camera measurements of 99mTc-DTPA. Biochim Biophys Acta (BBA)-General Subjects 1999, 1473(2-3):321-328.
86. Engstrom P.E., Ivarsson K., Tranberg K.G., Stenram U., Salford L.G., Persson B.R.R. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver. Anticancer Res 2001, 21(3B):1817-1822.
87. Gehl J., Geertsen P.F. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000, 10(6):585.
88. Mir L.M. Therapeutic perspectives of in vivo cell electropermeabilization* 1. Bioelectrochemistry 2001, 53(1):1-10.
89. Sersa C., Cemazar M., Miklavcic D., Chaplin D.J. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 1999, 19(5):4017-4022.
90. Sersa G., Beravs K., Cemaz ar M., Miklavcic D., Demsar F. Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electromagnetic Biol Med 1998, 17(2):299-306.
91. Ramirez L.H., Orlowski S., An D., Bindoula G., Dzodic R., Ardouin P., et al. Electrochemotherapy on liver tumours in rabbits. Br J Cancer 1998, 77(12):2104.
92. Engstrom P.E., Persson B.R.R., Brun A., Salford L.G. A new antitumor treatment combining radiation and electric pulses. Anticancer Res 2001, 21(3):1809-1816.
93. Sadadcharam M., Soden D.M., O'Sullivan G.C. Electrochemotherapy: an emerging cancer treatment. Int J Hyperthermia 2008, 24(3):263-273.
94. Hyacinthe M., Jaroszeski M.J., Dang V.V., Coppola D., Karl R.C., Gilbert R.A., et al. Electrically enhanced drug delivery for the treatment of soft tissue sarcoma. Cancer 1999, 85(2):409-417.
95. Mir L.M., Banoun H., Paoletti C. Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 1988, 175(1):15-25.
96. Pron G., Belehradek J., Mir L.M. Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun 1993, 194(1):333-337.
97. Pron G., Belehradek J., Orlowski S., Mir L.M. Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicity. Biochem Pharmacol 1994, 48(2):301-310.
98. Pron G., Mahrour N., Orlowski S., Tounekti O., Poddevin B., Belehradek J., et al. Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol 1999, 57(1):45-56.
99. Gehl J., Skovsgaard T., Mir L.M. Enhancement of cytotoxicity by electropermeabilization: an improved method for screening drugs. Anti-cancer Drugs 1998, 9(4):319.
100. Gately D.P., Howell S.B. Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 1993, 67(6):1171.
101. Sersa G., Cemazae M., Miklavcic D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 1995, 55(15):3450-3455.
102. Melvik J.E., Pettersen E.O., Gordon P.B., Seglen P.O. Increase in cis-dichlorodiammineplatinum (II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 1986, 22(12):1523-1530.
103. Mir L.M., Belehradek M., Domenge C., Orlowski S., Poddevin B., Belehradek J., et al. Electrochemotherapy, a new antitumor treatment: first clinical trial. Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1991, 313(13):613.
104. Bloom D.C., Goldfarb P.M. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck. Eur J Surg Oncol 2005, 31(9):1029-1035.
105. Burian M., Formanek M., Regele H. Electroporation therapy in head and neck cancer. Acta oto-laryngologica 2003, 123(2):264-268.
106. Byrne C.M., Thompson J.F., Johnston H., Hersey P., Quinn M.J., Michael Hughes T., et al. Treatment of metastatic melanoma using electroporation therapy with bleomycin (electrochemotherapy). Melanoma Res 2005, 15(1):45.
107. Kubota Y., Mir L.M., Nakada T., Sasagawa I., Suzuki H., Aoyama N. Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol 1998, 160(4):1426.
108. Panje W.R., Hier M.P., Garman G.R., Harrell E., Goldman A., Bloch I. Electroporation therapy of head and neck cancer. Annals otology rhinology laryngology 1998, 107(9 Pt 1):779.
109. Rodriguez-Cuevas S., Barroso-Bravo S., Almanza-Estrada J., Cristobal-Martinez L., Gonzalez-Rodriguez E. Electrochemotherapy in primary and metastatic skin tumors: phase ii trial using intralesional bleomycin. Arch Med Res 2001, 32(4):273-276.
110. Glass L.F., Pepine M.L., Fenske N.A., Jaroszeski M., Reintgen D.S., Heller R. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 1996, 132(11):1353.
111. Marty M., Sersa G., Garbay J.R., Gehl J., Collins C.G., Snoj M., et al. Electrochemotherapy-an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006, 4(11):3-13.
112. Matthiessen L.W., Johannesen H.H., Hendel H.W., Moss T., Kamby C., Gehl J. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncologica 2012, 51(6):713-721.
113. Campana L.G., Valpione S., Falci C., Mocellin S., Basso M., Corti L., et al. The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat 2012, 134(3):1169-1178.
114. Agerholm-Larsen B., Iversen H.K., Ibsen P., Moller J.M., Mahmood F., Jensen K.S., et al. Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011, 71(11):3753-3762.
115. Miklavcic D., Sersa G., Brecelj E., Gehl J., Soden D., Bianchi G., et al. Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput 2012, 50(12):1213-1225.
116. Linnert M., Iversen H.K., Gehl J. Multiple brain metastases-current management and perspectives for treatment with electrochemotherapy. Radiol Oncol 2012, 46(4):271-278.
117. Forde P.F., Bourke M.G., Salwa S., O'Sullivan G.C., Soden D.M. Minimally Invasive Intraluminal Tumor Ablation 2011, Springer, Clinical Aspects of Electrochemotherapy, pp. 137-141.
118. Domenge C., Orlowski S., Luboinski B., Baere T.D., Schwaab G., Belehradek J. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996, 77(5):956-963.
119. TM by means of invasive or non-invasive electrodes. Eur J Cancer 2006, 11(4):14-25.
120. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7(8):573-584.
121. Hall M.D., Okabe M., Shen D.W., Liang X.J., Gottesman M.M. The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy*. Annu Rev Pharmacol Toxicol 2008, 48:495-535.
122. Sersa G., Stabuc B., Cemazar M., Jancar B., Miklavcic D., Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients. Eur JCancer 1998, 34(8):1213-1218.
123. Mir L.M., Glass L.F., Sersa G., TeissiÃÀ J., Domenge C., Miklavcic D., et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 1998, 77(12):2336.
124. Snoj M., Rudolf Z., Cemazar M., Jancar B., Sersa G. Successful sphincter-saving treatment of anorectal malignant melanoma with electrochemotherapy, local excision and adjuvant brachytherapy. Anti-cancer Drugs 2005, 16(3):345.
125. Shimizu T., Nikaido T., Gomyo H., Yoshimura Y., Horiuchi A., Isobe K., et al. Electrochemotherapy for digital chondrosarcoma. J Orthop Sci 2003, 8(2):248-251.
126. Americal Cancer Society. Cancer facts and figures. http://www.cancer.org.